Cost-effectiveness of population-based screening for microalbuminuria in people with type 2 diabetes mellitus in India.
Sudalaimuthu Mathan KumarSaravanan EssakkySubramania R RajasulochanaSitanshu Sekhar KarParthibane SivanathamJeyanthi AnandrajSreejith ParameswaranBiju SomanKavitha RajsekharAntony StanleyPublished in: International journal of technology assessment in health care (2023)
Microalbuminuria screening was cost-effective at the threshold of one-time GDP per capita in India.
Keyphrases